Mater Research is a recognised leader in medical research. Our bench to bedside philosophy sees us working across Mater Health’s hospitals and health services, The University of Queensland, and the world-class Translational Research Institute (TRI). We are committed to working closely with Mater Health, Mater Education and our growing network of partners and collaborators to turn scientific discovery into the best possible treatment, care, and outcomes for patients and our broader community. 

Our key focus areas are Cancer biology and care , Chronic disease biology and care , Implementing evidence to improve health , Mothers', babies and women's health , Neurosciences and cognitive health , Optimising acute care .

Mater update
Read the latest information on the novel coronavirus (COVID-19)

Latest News

Mater researcher Professor Vicki Clifton and her team want to know how parent’s lifestyle choices impact their children.



Journey to discovering support for healthy families in Queensland

A new era of ovarian cancer research has begun, with Queensland studies receiving a record-breaking four out of eight grants.



Multi-grant success for ovarian cancer research

Dr Lucy Burr has expansive knowledge of respiratory illness which is helping the taskforce build living guidelines for the treatment of COVID-19.



Mater part of national pandemic response taskforce

National Volunteer Week is a time to celebrate and give thanks to those who help to support various initiatives by donating their valuable...



When opportunity wheels by

We are pleased to announce the 2020 Strategic Grant for Outstanding Women.



Promising researcher awarded the Outstanding Women’s Grant

Professor John Hooper and his team based at TRI, receives accolade that will allow them to progress ovarian cancer research to clinical trial.



Accolade for ovarian cancer research achievement

A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia.



Mater research shows positive signs for acute myeloid leukaemia patients

Researchers from Mater Research are pioneering a new approach to symptom relief by trialling medicinal cannabis in advanced cancer patients...



Researchers trial medicinal cannabis treatment for advanced cancer patients

Mater Misericordiae Ltd (MML) is seeking volunteers to join the Human Research Ethics Committee (HREC).



Have you considered joining a Human Research Ethics Committee?

Queensland Scientists have discovered a possible link between Parkinson’s disease and a gene impacted by a neurotoxin found in blue-green algae.



Parkinson’s disease linked to gene targeted by blue-green algae toxin